Resveratrol Promotes Self-digestion to Put Cancer to Sleep

Alessandra Ferraresi1, Suyanee Thongchot1, Ciro Isidoro1

  • 1Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.

PubMed

Insights

Resveratrol, a natural polyphenol, shows promise in preventing and treating cancer. It promotes tumor dormancy through epigenetic changes, impacting cancer-associated fibroblasts and reducing inflammation.

Area of Science:

  • Oncology
  • Epigenetics
  • Natural Products Chemistry

Background:

  • Resveratrol, a polyphenol found in various foods, exhibits anticancer properties.
  • Its chemopreventive and curative effects are linked to epigenetic modifications in cancer pathways.

Purpose of the Study:

  • To highlight laboratory findings on resveratrol's potential in cancer prevention and treatment.
  • To explore its role in promoting epigenetic-mediated, autophagy-dependent tumor dormancy.

Main Methods:

  • Focus on laboratory research examining resveratrol's effects.
  • Analysis of epigenetic modifications, autophagy, cancer-associated fibroblasts, and cytokine production.

Main Results:

  • Resveratrol promotes tumor dormancy via epigenetic mechanisms.
  • This effect involves re-educating cancer-associated fibroblasts.
  • Reduced inflammatory cytokine production in the tumor microenvironment was observed.

Conclusions:

  • Resveratrol demonstrates potential for cancer prevention and cure.
  • Epigenetic modulation of tumor dormancy is a key mechanism.
  • Further discussion on clinical translation of resveratrol's anticancer activity is warranted.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K